IMMUNIC, INC. — Director's Dealing 2019

Jul 24, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2019-07-22

Reporting Person: Neermann Joerg (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-07-22	Stock Option	$13.63	A	29959	Acquired	2029-07-22	Common Stock (29959)	Direct

Footnotes

F1: 9,986 of the options vest in monthly increments over a period of one year from the grant date, and 19,973 of the options vest in monthly increments over a period of three years from the grant date.